English

WASATCH PHARMACEUTICAL INC

EDGAR

Filing (10QSB) · filed 2002-12-03

30 filing records in this dataset, filed from 1996-07-16 to 2002-12-03. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

10.6 thousand USD

2002-09-30 · USD

Exact inputs and evidence

Revenue: 10601 USD Source

Net margin

-4,948.82%

2002-09-30 · %

Exact inputs and evidence

Net Income: -524624 USD Source
Revenue: 10601 USD Source

Operating cash flow

16 thousand USD

2002-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -721201 USD Source
Operating Cash Flow: -737183 USD Source

Cash and cash equivalents: 430 USD 2002-09-30 Source
Exact value

430 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

68.3 million USD

2001-10-01 – 2002-09-30

Exact inputs and evidence

Revenue: 52959000 USD · 2001-01-01 – 2001-12-31 Source
Revenue: 42207 USD · 2001-01-01 – 2001-09-30 Source
Revenue: 15406000 USD · 2002-01-01 – 2002-03-31 Source
Revenue: 10417 USD · 2002-04-01 – 2002-06-30 Source
Revenue: 10601 USD · 2002-07-01 – 2002-09-30 Source

Net income

-3.86 billion USD

2001-10-01 – 2002-09-30

Exact inputs and evidence

Net income: -3138894000 USD · 2001-01-01 – 2001-12-31 Source
Net income: -2352703 USD · 2001-01-01 – 2001-09-30 Source
Net income: -719882000 USD · 2002-01-01 – 2002-03-31 Source
Net income: -973614 USD · 2002-04-01 – 2002-06-30 Source
Net income: -524624 USD · 2002-07-01 – 2002-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2002-12-03.

Financial data available through: 2001-12-31.

Coverage by financial measure

Revenue: 7 of 11 periods available· newest 2001-12-31
Operating income: 4 of 11 periods available· newest 1999-12-31
Net income: 9 of 11 periods available· newest 2001-12-31
Operating cash flow: 6 of 11 periods available· newest 2001-12-31
capital expenditure: No compatible figures in this window
Total assets: 7 of 11 periods available· newest 2001-12-31
Total liabilities: 7 of 11 periods available· newest 2001-12-31
Current assets: 7 of 11 periods available· newest 2001-12-31
Current liabilities: 2 of 11 periods available· newest 1996-12-31
Cash and cash equivalents: 5 of 11 periods available· newest 2001-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+77.8%

Prior period

USD 29.79 million

2000-01-01 – 2000-12-31
Current period

USD 52.96 million

2001-01-01 – 2001-12-31

Exact inputs and evidence

52959000 − 29785000 = 23174000 USD

29785000 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
52959000 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · WASATCH PHARMACEUTICAL INC · 2001-12-31 WASATCH PHARMACEUTICAL INC (edgar:37848) Year-over-year change in Revenue: 23174000 USD Concept: fundies:Revenue Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T07:56:09Z Snapshot: 4e10dee1682fb1680821af202a411691461ed3b1ec2536e023b725c9a0dcb35e Dimensions: Consolidated View: https://fundies.io/companies/edgar/37848?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 52959000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/37848/0001038838-02-000314.txt#1926 Input fundies:Revenue: 29785000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/37848/0001038838-02-000314.txt#1926
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 785.97 million

Prior period

−USD 2.35 billion

2000-01-01 – 2000-12-31
Current period

−USD 3.14 billion

2001-01-01 – 2001-12-31

Exact inputs and evidence

-3138894000 − -2352925000 = -785969000 USD

-2352925000 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
-3138894000 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · WASATCH PHARMACEUTICAL INC · 2001-12-31 WASATCH PHARMACEUTICAL INC (edgar:37848) Year-over-year change in Net income: -785969000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T07:56:09Z Snapshot: 4e10dee1682fb1680821af202a411691461ed3b1ec2536e023b725c9a0dcb35e Dimensions: Consolidated View: https://fundies.io/companies/edgar/37848?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -3138894000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/37848/0001038838-02-000314.txt#2132 Input fundies:NetIncome: -2352925000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/37848/0001038838-02-000314.txt#2132
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 492.08 million

Prior period

−USD 1.17 billion

2000-01-01 – 2000-12-31
Current period

−USD 1.66 billion

2001-01-01 – 2001-12-31

Exact inputs and evidence

-1661218000 − -1169134000 = -492084000 USD

-1169134000 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
-1661218000 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · WASATCH PHARMACEUTICAL INC · 2001-12-31 WASATCH PHARMACEUTICAL INC (edgar:37848) Year-over-year change in Operating cash flow: -492084000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T07:56:09Z Snapshot: 4e10dee1682fb1680821af202a411691461ed3b1ec2536e023b725c9a0dcb35e Dimensions: Consolidated View: https://fundies.io/companies/edgar/37848?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -1661218000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/37848/0001038838-02-000314.txt#2149 Input fundies:OperatingCashFlow: -1169134000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/37848/0001038838-02-000314.txt#2149
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2001 2001-01-01 – 2001-12-31

Revenue USD 52.96 million 100% of revenue
Operating costs Derived Unavailable An input is unavailable.
Operating income Unavailable An input is unavailable.
Tax, interest and other Derived Unavailable An input is unavailable.
Net income −USD 3.14 billion −5,927% of revenue

Cash

Operating cash flow −USD 1.66 billion −3,137% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1995 Not shown: operating income or net income is not reported.
1996 Operating loss: operating costs were 108% of revenue.
1997 Operating loss: operating costs were 118% of revenue.
1998 Net loss: net income was −1,790% of revenue.
1999 Net loss: net income was −2,619% of revenue.
2000 Not shown: operating income or net income is not reported.
2001 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1995 1995-01-01 – 1995-12-31	225041	Unavailable	Unavailable	Unavailable	-451255	Unavailable	Source 1995-01-01 – 1995-12-31: 225041 USD Inspect Revenue Open source 1995-01-01 – 1995-12-31: -451255 USD Inspect Net Income Open source
1996 1996-01-01 – 1996-12-31	114244	123060 Derived	-8816	495292 Derived	-504108	Unavailable	Source 1996-01-01 – 1996-12-31: 114244 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -8816 USD Inspect Operating Income Open source 1996-01-01 – 1996-12-31: -504108 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: -400466 USD Inspect Operating Cash Flow Open source
1997 1997-01-01 – 1997-12-31	101843	119812 Derived	-17969	1163601 Derived	-1181570	Unavailable	Source 1997-01-01 – 1997-12-31: 101843 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -17969 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: -1181570 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: -510911 USD Inspect Operating Cash Flow Open source
1998 1998-01-01 – 1998-12-31	81476	81476 Derived	0	1458683 Derived	-1458683	Unavailable	Source 1998-01-01 – 1998-12-31: 81476 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: 0 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -1458683 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -1065907 USD Inspect Operating Cash Flow Open source
1999 1999-01-01 – 1999-12-31	44619	44619 Derived	0	1168750 Derived	-1168750	Unavailable	Source 1999-01-01 – 1999-12-31: 44619 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: 0 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -1168750 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -771178 USD Inspect Operating Cash Flow Open source
2000 2000-01-01 – 2000-12-31	29785000	Unavailable	Unavailable	Unavailable	-2352925000	Unavailable	Source 2000-01-01 – 2000-12-31: 29785000 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -2352925000 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -1169134000 USD Inspect Operating Cash Flow Open source
2001 2001-01-01 – 2001-12-31	52959000	Unavailable	Unavailable	Unavailable	-3138894000	Unavailable	Source 2001-01-01 – 2001-12-31: 52959000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -3138894000 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -1661218000 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 53M 2001

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Revenue	225041	Revenue: 225041 Open source
19961996-12-31	Revenue	114244	Revenue: 114244 Open source
19971997-12-31	Revenue	101843	Revenue: 101843 Open source
19981998-12-31	Revenue	81476	Revenue: 81476 Open source
19991999-12-31	Revenue	44619	Revenue: 44619 Open source
20002000-12-31	Revenue	29785000	Revenue: 29785000 Open source
20012001-12-31	Revenue	52959000	Revenue: 52959000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

77.8% 2001

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Year over year	No prior comparable period	Revenue: 225041 Open source
19961996-12-31	Year over year	-49.2%	Revenue: 114244 Open source Revenue: 225041 Open source
19971997-12-31	Year over year	-10.9%	Revenue: 101843 Open source Revenue: 114244 Open source
19981998-12-31	Year over year	-20%	Revenue: 81476 Open source Revenue: 101843 Open source
19991999-12-31	Year over year	-45.2%	Revenue: 44619 Open source Revenue: 81476 Open source
20002000-12-31	Year over year	66,654.1%	Revenue: 29785000 Open source Revenue: 44619 Open source
20012001-12-31	Year over year	77.8%	Revenue: 52959000 Open source Revenue: 29785000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 0% 1999

Net margin -5,927% 2001

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
1995-12-31	Operating margin	Not reported	Revenue: 225041 Open source
19961996-12-31	Operating margin	-7.7%	Operating Income: -8816 Open source Revenue: 114244 Open source
19971997-12-31	Operating margin	-17.6%	Operating Income: -17969 Open source Revenue: 101843 Open source
19981998-12-31	Operating margin	0%	Operating Income: 0 Open source Revenue: 81476 Open source
19991999-12-31	Operating margin	0%	Operating Income: 0 Open source Revenue: 44619 Open source
2000-12-31	Operating margin	Not reported	Revenue: 29785000 Open source
2001-12-31	Operating margin	Not reported	Revenue: 52959000 Open source
19951995-12-31	Net margin	-200.5%	Net Income: -451255 Open source Revenue: 225041 Open source
19961996-12-31	Net margin	-441.3%	Net Income: -504108 Open source Revenue: 114244 Open source
19971997-12-31	Net margin	-1,160.2%	Net Income: -1181570 Open source Revenue: 101843 Open source
19981998-12-31	Net margin	-1,790.3%	Net Income: -1458683 Open source Revenue: 81476 Open source
19991999-12-31	Net margin	-2,619.4%	Net Income: -1168750 Open source Revenue: 44619 Open source
20002000-12-31	Net margin	-7,899.7%	Net Income: -2352925000 Open source Revenue: 29785000 Open source
20012001-12-31	Net margin	-5,927%	Net Income: -3138894000 Open source Revenue: 52959000 Open source
19951995-12-31	Free cash flow margin	Not reported	Revenue: 225041 Open source
19961996-12-31	Free cash flow margin	Not reported	Revenue: 114244 Open source Operating Cash Flow: -400466 Open source
19971997-12-31	Free cash flow margin	Not reported	Revenue: 101843 Open source Operating Cash Flow: -510911 Open source
19981998-12-31	Free cash flow margin	Not reported	Revenue: 81476 Open source Operating Cash Flow: -1065907 Open source
19991999-12-31	Free cash flow margin	Not reported	Revenue: 44619 Open source Operating Cash Flow: -771178 Open source
20002000-12-31	Free cash flow margin	Not reported	Revenue: 29785000 Open source Operating Cash Flow: -1169134000 Open source
20012001-12-31	Free cash flow margin	Not reported	Revenue: 52959000 Open source Operating Cash Flow: -1661218000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -1.7B 2001

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Operating cash flow	Not reported	No source recorded
19961996-12-31	Operating cash flow	-400466	Operating Cash Flow: -400466 Open source
19971997-12-31	Operating cash flow	-510911	Operating Cash Flow: -510911 Open source
19981998-12-31	Operating cash flow	-1065907	Operating Cash Flow: -1065907 Open source
19991999-12-31	Operating cash flow	-771178	Operating Cash Flow: -771178 Open source
20002000-12-31	Operating cash flow	-1169134000	Operating Cash Flow: -1169134000 Open source
20012001-12-31	Operating cash flow	-1661218000	Operating Cash Flow: -1661218000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Free cash flow	Unavailable	No source recorded
19961996-12-31	Free cash flow	Unavailable	Operating Cash Flow: -400466 Open source
19971997-12-31	Free cash flow	Unavailable	Operating Cash Flow: -510911 Open source
19981998-12-31	Free cash flow	Unavailable	Operating Cash Flow: -1065907 Open source
19991999-12-31	Free cash flow	Unavailable	Operating Cash Flow: -771178 Open source
20002000-12-31	Free cash flow	Unavailable	Operating Cash Flow: -1169134000 Open source
20012001-12-31	Free cash flow	Unavailable	Operating Cash Flow: -1661218000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

997.3% 2001

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Liabilities / assets	2,228.8%	Total Liabilities: 1071038 Open source Total Assets: 48054 Open source
19961996-12-31	Liabilities / assets	34.2%	Total Liabilities: 1290214 Open source Total Assets: 3775069 Open source
19971997-12-31	Liabilities / assets	2,770.3%	Total Liabilities: 1722313 Open source Total Assets: 62170 Open source
19981998-12-31	Liabilities / assets	9,567.3%	Total Liabilities: 2945183 Open source Total Assets: 30784 Open source
19991999-12-31	Liabilities / assets	7,607.5%	Total Liabilities: 3387562 Open source Total Assets: 44529 Open source
20002000-12-31	Liabilities / assets	1,014.1%	Total Liabilities: 4226289 Open source Total Assets: 416752 Open source
20012001-12-31	Liabilities / assets	997.3%	Total Liabilities: 5912838000 Open source Total Assets: 592890000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.02× 1996

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Current assets / current liabilities	0.01×	Current Assets: 13332 Open source Current Liabilities: 929721 Open source
19961996-12-31	Current assets / current liabilities	0.02×	Current Assets: 30102 Open source Current Liabilities: 1285214 Open source
19971997-12-31	Current assets / current liabilities	Not reported	Current Assets: 41403 Open source
19981998-12-31	Current assets / current liabilities	Not reported	Current Assets: 17522 Open source
19991999-12-31	Current assets / current liabilities	Not reported	Current Assets: 24632 Open source
20002000-12-31	Current assets / current liabilities	Not reported	Current Assets: 191248 Open source
20012001-12-31	Current assets / current liabilities	Not reported	Current Assets: 348589000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1993 1993-01-01 – 1993-12-31	−USD 92,931 Exact value Exact value: -92931 USD 1993-01-01 – 1993-12-31: -92931 USD Inspect Net Income Open source Share or cite Citation for Net Income · WASATCH PHARMACEUTICAL INC · 1993-12-31 WASATCH PHARMACEUTICAL INC (edgar:37848) Net Income: -92931 USD Concept: fundies:NetIncome Period: 1993-01-01 to 1993-12-31 Values: Latest reported Published: 2026-11-02T07:56:09Z Snapshot: 4e10dee1682fb1680821af202a411691461ed3b1ec2536e023b725c9a0dcb35e Dimensions: Consolidated View: https://fundies.io/companies/edgar/37848/explain?concept=fundies%3ANetIncome&period=1993-12-31&surface=latest&period_type=duration&start=1993-01-01&unit=USD&dimensions= Input fundies:NetIncome: -92931 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/37848/0000931731-96-000185.txt#1407 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
1994 1994-01-01 – 1994-12-31	−USD 365,189 Exact value Exact value: -365189 USD 1994-01-01 – 1994-12-31: -365189 USD Inspect Net Income Open source Share or cite Citation for Net Income · WASATCH PHARMACEUTICAL INC · 1994-12-31 WASATCH PHARMACEUTICAL INC (edgar:37848) Net Income: -365189 USD Concept: fundies:NetIncome Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T07:56:09Z Snapshot: 4e10dee1682fb1680821af202a411691461ed3b1ec2536e023b725c9a0dcb35e Dimensions: Consolidated View: https://fundies.io/companies/edgar/37848/explain?concept=fundies%3ANetIncome&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:NetIncome: -365189 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/37848/0000931731-96-000185.txt#1407 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
1995 1995-01-01 – 1995-12-31	−USD 451,255 Exact value Exact value: -451255 USD 1995-01-01 – 1995-12-31: -451255 USD Inspect Net Income Open source Share or cite Citation for Net Income · WASATCH PHARMACEUTICAL INC · 1995-12-31 WASATCH PHARMACEUTICAL INC (edgar:37848) Net Income: -451255 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T07:56:09Z Snapshot: 4e10dee1682fb1680821af202a411691461ed3b1ec2536e023b725c9a0dcb35e Dimensions: Consolidated View: https://fundies.io/companies/edgar/37848/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: -451255 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/37848/0001012895-97-000037.txt#1567 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
1996 1996-01-01 – 1996-12-31	−USD 504,108 Exact value Exact value: -504108 USD 1996-01-01 – 1996-12-31: -504108 USD Inspect Net Income Open source Share or cite Citation for Net Income · WASATCH PHARMACEUTICAL INC · 1996-12-31 WASATCH PHARMACEUTICAL INC (edgar:37848) Net Income: -504108 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T07:56:09Z Snapshot: 4e10dee1682fb1680821af202a411691461ed3b1ec2536e023b725c9a0dcb35e Dimensions: Consolidated View: https://fundies.io/companies/edgar/37848/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -504108 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/37848/0001038838-00-000254.txt#1970 The citation records this snapshot. The page link may show a newer release later.	−USD 400,466 Exact value Exact value: -400466 USD 1996-01-01 – 1996-12-31: -400466 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · WASATCH PHARMACEUTICAL INC · 1996-12-31 WASATCH PHARMACEUTICAL INC (edgar:37848) Operating Cash Flow: -400466 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T07:56:09Z Snapshot: 4e10dee1682fb1680821af202a411691461ed3b1ec2536e023b725c9a0dcb35e Dimensions: Consolidated View: https://fundies.io/companies/edgar/37848/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -400466 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/37848/0001038838-00-000254.txt#1987 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1997 1997-01-01 – 1997-12-31	−USD 1.18 million Exact value Exact value: -1181570 USD 1997-01-01 – 1997-12-31: -1181570 USD Inspect Net Income Open source Share or cite Citation for Net Income · WASATCH PHARMACEUTICAL INC · 1997-12-31 WASATCH PHARMACEUTICAL INC (edgar:37848) Net Income: -1181570 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T07:56:09Z Snapshot: 4e10dee1682fb1680821af202a411691461ed3b1ec2536e023b725c9a0dcb35e Dimensions: Consolidated View: https://fundies.io/companies/edgar/37848/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1181570 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/37848/0001038838-00-000264.txt#2078 The citation records this snapshot. The page link may show a newer release later.	−USD 510,911 Exact value Exact value: -510911 USD 1997-01-01 – 1997-12-31: -510911 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · WASATCH PHARMACEUTICAL INC · 1997-12-31 WASATCH PHARMACEUTICAL INC (edgar:37848) Operating Cash Flow: -510911 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T07:56:09Z Snapshot: 4e10dee1682fb1680821af202a411691461ed3b1ec2536e023b725c9a0dcb35e Dimensions: Consolidated View: https://fundies.io/companies/edgar/37848/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -510911 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/37848/0001038838-00-000264.txt#2095 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1998 1998-01-01 – 1998-12-31	−USD 1.46 million Exact value Exact value: -1458683 USD 1998-01-01 – 1998-12-31: -1458683 USD Inspect Net Income Open source Share or cite Citation for Net Income · WASATCH PHARMACEUTICAL INC · 1998-12-31 WASATCH PHARMACEUTICAL INC (edgar:37848) Net Income: -1458683 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T07:56:09Z Snapshot: 4e10dee1682fb1680821af202a411691461ed3b1ec2536e023b725c9a0dcb35e Dimensions: Consolidated View: https://fundies.io/companies/edgar/37848/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1458683 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/37848/0001038838-00-000274.txt#2020 The citation records this snapshot. The page link may show a newer release later.	−USD 1.07 million Exact value Exact value: -1065907 USD 1998-01-01 – 1998-12-31: -1065907 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · WASATCH PHARMACEUTICAL INC · 1998-12-31 WASATCH PHARMACEUTICAL INC (edgar:37848) Operating Cash Flow: -1065907 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T07:56:09Z Snapshot: 4e10dee1682fb1680821af202a411691461ed3b1ec2536e023b725c9a0dcb35e Dimensions: Consolidated View: https://fundies.io/companies/edgar/37848/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1065907 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/37848/0001038838-00-000274.txt#2036 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1999 1999-01-01 – 1999-12-31	−USD 1.17 million Exact value Exact value: -1168750 USD 1999-01-01 – 1999-12-31: -1168750 USD Inspect Net Income Open source Share or cite Citation for Net Income · WASATCH PHARMACEUTICAL INC · 1999-12-31 WASATCH PHARMACEUTICAL INC (edgar:37848) Net Income: -1168750 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T07:56:09Z Snapshot: 4e10dee1682fb1680821af202a411691461ed3b1ec2536e023b725c9a0dcb35e Dimensions: Consolidated View: https://fundies.io/companies/edgar/37848/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1168750 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/37848/0001038838-01-500003.txt#1957 The citation records this snapshot. The page link may show a newer release later.	−USD 771,178 Exact value Exact value: -771178 USD 1999-01-01 – 1999-12-31: -771178 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · WASATCH PHARMACEUTICAL INC · 1999-12-31 WASATCH PHARMACEUTICAL INC (edgar:37848) Operating Cash Flow: -771178 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T07:56:09Z Snapshot: 4e10dee1682fb1680821af202a411691461ed3b1ec2536e023b725c9a0dcb35e Dimensions: Consolidated View: https://fundies.io/companies/edgar/37848/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -771178 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/37848/0001038838-00-000274.txt#2036 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2000 2000-01-01 – 2000-12-31	−USD 2.35 billion Exact value Exact value: -2352925000 USD 2000-01-01 – 2000-12-31: -2352925000 USD Inspect Net Income Open source Share or cite Citation for Net Income · WASATCH PHARMACEUTICAL INC · 2000-12-31 WASATCH PHARMACEUTICAL INC (edgar:37848) Net Income: -2352925000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T07:56:09Z Snapshot: 4e10dee1682fb1680821af202a411691461ed3b1ec2536e023b725c9a0dcb35e Dimensions: Consolidated View: https://fundies.io/companies/edgar/37848/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2352925000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/37848/0001038838-02-000314.txt#2132 The citation records this snapshot. The page link may show a newer release later.	−USD 1.17 billion Exact value Exact value: -1169134000 USD 2000-01-01 – 2000-12-31: -1169134000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · WASATCH PHARMACEUTICAL INC · 2000-12-31 WASATCH PHARMACEUTICAL INC (edgar:37848) Operating Cash Flow: -1169134000 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T07:56:09Z Snapshot: 4e10dee1682fb1680821af202a411691461ed3b1ec2536e023b725c9a0dcb35e Dimensions: Consolidated View: https://fundies.io/companies/edgar/37848/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1169134000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/37848/0001038838-02-000314.txt#2149 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2001 2001-01-01 – 2001-12-31	−USD 3.14 billion Exact value Exact value: -3138894000 USD 2001-01-01 – 2001-12-31: -3138894000 USD Inspect Net Income Open source Share or cite Citation for Net Income · WASATCH PHARMACEUTICAL INC · 2001-12-31 WASATCH PHARMACEUTICAL INC (edgar:37848) Net Income: -3138894000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T07:56:09Z Snapshot: 4e10dee1682fb1680821af202a411691461ed3b1ec2536e023b725c9a0dcb35e Dimensions: Consolidated View: https://fundies.io/companies/edgar/37848/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3138894000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/37848/0001038838-02-000314.txt#2132 The citation records this snapshot. The page link may show a newer release later.	−USD 1.66 billion Exact value Exact value: -1661218000 USD 2001-01-01 – 2001-12-31: -1661218000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · WASATCH PHARMACEUTICAL INC · 2001-12-31 WASATCH PHARMACEUTICAL INC (edgar:37848) Operating Cash Flow: -1661218000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T07:56:09Z Snapshot: 4e10dee1682fb1680821af202a411691461ed3b1ec2536e023b725c9a0dcb35e Dimensions: Consolidated View: https://fundies.io/companies/edgar/37848/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1661218000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/37848/0001038838-02-000314.txt#2149 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

30 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000037848, 37848, edgar:37848

WASATCH PHARMACEUTICAL INC

Latest quarter

Revenue

Net margin

Operating cash flow

Trailing twelve months

Revenue

Net income

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2001 2001-01-01 – 2001-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation